Skip to content

3Accepted Jan 14, 8:07 AM ET

OcuMension Therapeutics 3

EYPTEyePoint Pharmaceuticals, Inc.

Accepted (ET)

8:07 AM

Jan 14, 2021

Filed

Jan 14, 2021

Documents

2

Size

13.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.